BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 10096172)

  • 1. [Vascular effects of gestagens--biochemistry versus epidemiology].
    Kuhl H
    Zentralbl Gynakol; 1999; 121(2):67-78. PubMed ID: 10096172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hormonal contraception and substitution therapy: the importance of progestogen for cardiovascular diseases].
    Kuhl H
    Geburtshilfe Frauenheilkd; 1992 Nov; 52(11):653-62. PubMed ID: 1452000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM; Fini M
    Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cardiovascular effects and estrogen/gestagen substitution therapy].
    Kuhl H
    Ther Umsch; 1994 Nov; 51(11):748-54. PubMed ID: 7839333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of progestogens on haemostasis.
    Kuhl H
    Maturitas; 1996 May; 24(1-2):1-19. PubMed ID: 8794429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The rationale for a wider range of progestogens.
    Skouby SO
    Climacteric; 2000 Dec; 3 Suppl 2():14-20. PubMed ID: 11379382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the proliferative effects of estradiol and conjugated equine estrogens on human breast cancer cells and impact of continuous combined progestogen addition.
    Mueck AO; Seeger H; Wallwiener D
    Climacteric; 2003 Sep; 6(3):221-7. PubMed ID: 14567770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationale for hormone replacement therapy in atherosclerosis prevention.
    Wagner JD
    J Reprod Med; 2000 Mar; 45(3 Suppl):245-58. PubMed ID: 10756506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of estradiol and progestogens on tumor-necrosis factor-alpha-induced changes of biochemical markers for breast cancer growth and metastasis.
    Seeger H; Wallwiener D; Mueck AO
    Gynecol Endocrinol; 2008 Oct; 24(10):576-9. PubMed ID: 19012101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Action of natural estrogens on the vessel wall: molecular mechanisms and clinical implications].
    Lüscher TF; Barton M; Wight E; Espinosa E; Yang Z
    Schweiz Med Wochenschr; 1996 Oct; 126(41):1748-55. PubMed ID: 8966507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Progestogens, progesterone, coagulation and vascular tone].
    Schved JF; Biron C
    Gynecol Obstet Fertil; 2002 May; 30(5):421-6. PubMed ID: 12087938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation by progestogens of the effects of oestrogen on hepatic endocrine function in postmenopausal women.
    Nugent AG; Leung KC; Sullivan D; Reutens AT; Ho KK
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):690-8. PubMed ID: 14974909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of hormone treatment on hemostasis variables.
    Kluft C
    Climacteric; 2007 Oct; 10 Suppl 2():32-7. PubMed ID: 17882670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progestogens and target tissues: vascular systems.
    Mueck AO; Seeger H
    Maturitas; 2009 Apr; 62(4):356-61. PubMed ID: 19157733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progestogen therapies: differences in clinical effects?
    Wiegratz I; Kuhl H
    Trends Endocrinol Metab; 2004 Aug; 15(6):277-85. PubMed ID: 15358281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacology of estrogens and progestogens: influence of different routes of administration.
    Kuhl H
    Climacteric; 2005 Aug; 8 Suppl 1():3-63. PubMed ID: 16112947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormone replacement therapy and cancer.
    Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
    Genazzani AR; Gadducci A; Gambacciani M
    Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-dependent changes of the ratio of apoptosis to proliferation by norethisterone and medroxyprogesterone acetate in human breast epithelial cells.
    Seeger H; Rakov V; Mueck AO
    Horm Metab Res; 2005 Aug; 37(8):468-73. PubMed ID: 16138258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic and clinical effects of progestogens.
    Wiegratz I; Kuhl H
    Eur J Contracept Reprod Health Care; 2006 Sep; 11(3):153-61. PubMed ID: 17056444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.